Hold on, Justice Ginsburg. America needs you!
In a phone interview, Matt Fisher, a partner with Mirick O’Connell, said CMS’s latest actions regarding virtual care are beneficial but noted doctors shouldn’t forget about the privacy and security side of the coin.
The Psychopharmacologic Drugs Advisory Committee will meet on Thursday to vote on whether to recommend the FDA approve the drug, ALKS 5461, an opioid for major depressive disorder.
Accusations of ‘freeloading’ seen as misleading, and the proposed changes — which would start in 2020 — wouldn’t help patients covered under Part D or commercial plans.
Barth had been with the organization for around two decades, according to his LinkedIn.
A legal expert compared mandatory prices in ads to food labeling, but another expert said mandating them risks scaring patients out of taking life-saving medicines.
The indictment alleges that as part of the scheme, which ran from June 2015 to April 2018, the defendants submitted no less than $931 million in fraudulent claims for payment.
The FDA last week issued the draft guidance, under which it would publicly state if it denied branded drugmakers’ citizen petitions because they were designed to delay generic market entry.